Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin

被引：0
|
作者：
Riddle, Matthew
Zhang, Bei
Maier, Holly
Wilhelm, Ken
Kolterman, Orville
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [41] Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients
    Hollander, P
    Maggs, DG
    Ruggles, JA
    Fineman, M
    Shen, L
    Kolterman, OG
    Weyer, C
    OBESITY RESEARCH, 2004, 12 (04): : 661 - 668
  • [42] Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
    Inzucchi, S. E.
    Nauck, M. A.
    Hehnke, U.
    Woerle, H-J.
    von Eynatten, M.
    Henry, R. R.
    DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 868 - 877
  • [43] In uncontrolled type 2 diabetes, CBT improved glycemic control and reduced depression
    Bronson, David L.
    Franco, Kathleen S.
    ANNALS OF INTERNAL MEDICINE, 2014, 161 (04)
  • [44] Comparison of Mealtime Pramlintide, Insulin, or a Combination of Both, When Added to Basal Insulin Treatment in Patients with Type 2 Diabetes
    Karounos, Dennis
    Pencek, Rich
    Huang, Wenying
    Miller, Stephan
    Lutz, Karen
    Porter, Lisa
    DIABETES, 2009, 58 : A32 - A32
  • [45] Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes - A 1-year randomized controlled trial
    Hollander, PA
    Levy, P
    Fineman, M
    Maggs, DG
    Shen, LZ
    Strobel, SA
    Weyer, C
    Kolterman, OG
    DIABETES CARE, 2003, 26 (03) : 784 - 790
  • [46] The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis
    Singh-Franco, D.
    Perez, A.
    Harrington, C.
    DIABETES OBESITY & METABOLISM, 2011, 13 (02): : 169 - 180
  • [47] Comparison of mealtime pramlintide, insulin, or a combination of both, when added to basal insulin treatment in patients with type 2 diabetes
    Karounos, D.
    Pencek, R.
    Huang, W.
    Miller, S.
    Lutz, K.
    Porter, L.
    DIABETOLOGIA, 2009, 52 : S358 - S358
  • [48] Glycemic Control and Adherence to Basal Insulin Therapy in Taiwanese Patients with Type 2 Diabetes (T2D)
    Chien, Ming-Nan
    Chen, Yen-Ling
    Hung, Yi-Jen
    Wang, Shu-Yi
    Lu, Wen-Tsung
    Chen, Chih-Hung
    Lin, Ching-Ling
    Huang, Tze-Pao
    Tsai, Ming-Han
    Tseng, Wei-Kung
    Wu, Ta-Jen
    Ho, Cheng
    Lin, Wen-Yu
    Chen, Bill
    Chuang, Lee-Ming
    DIABETES, 2014, 63 : A600 - A600
  • [49] Glycemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, R
    Ways, K
    DIABETES, 2004, 53 : A121 - A121
  • [50] 52 weeks pramlintide therapy as an adjunct to insulin improved metabolic control in people with type 2 diabetes
    Fineman, M
    Gottlieb, A
    Skare, S
    Kolterman, O
    DIABETOLOGIA, 2000, 43 : A204 - A204
12345